CAMP4 THERAPEUTICS CORPORATION
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1,872.6% | -22.0% | – | – | – | -1,731.3% | -1,665.0% | -690.9% | -1,410.9% | 1,808.3% | -848.6% | -713.1% | -678.2% | |
| 122.9% | 0.8% | – | – | – | 64.1% | 49.1% | 28.7% | 52.3% | 106.9% | 40.2% | 28.9% | 43.2% | |
| 206.3% | 1.2% | – | – | – | 122.2% | 100.3% | 66.9% | 123.8% | 330.7% | 113.8% | 108.5% | 131.4% | |
| 1,024.6% | -0.3% | – | – | – | 117.8% | -433.7% | 28.6% | -46.4% | 4,790.2% | -66.8% | -150.9% | 302.5% | |
| 59.1% | 0.5% | – | – | – | 40.3% | 32.5% | 0.0% | 0.0% | 0.0% | 0.0% | 7.3% | 3.1% | |
| -59.1% | -0.5% | – | – | – | -40.3% | -32.5% | -18.6% | 4.5% | – | – | -7.3% | – | |
| – | – | – | – | – | -14.7% | -4.2% | -2.9% | -1.8% | -5.2% | 0.0% | 0.0% | -0.8% | |
| -58.0% | -0.1% | – | – | – | 11,205.8% | -17.6% | 4.8% | 5,960.3% | 8,214.1% | 4.4% | 0.2% | 1,803.4% | |
| -1,989.7% | -22.5% | – | – | – | 9,434.2% | -1,715.2% | -686.1% | 4,553.8% | 10,022.4% | -844.2% | -720.1% | 1,123.0% | |
| -1,931.7% | -22.4% | – | – | – | -1,771.6% | -1,697.6% | -690.9% | -1,410.9% | 1,808.3% | -848.6% | -720.3% | -681.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.